Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-23

Clinical Trial Update: Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism [NA]

View source ↗

Summary

A ClinicalTrials.gov update notes that the study aimed at attenuating post-operative insulin resistance and promoting protein anabolism has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Pre-Diabetes, Major Lung or Abdominal Surgery | NA | Status: TERMINATED